Drug Type Shared antigen vaccine, Therapeutic vaccine |
Synonyms IO 101, IO101 |
Target |
Action inhibitors |
Mechanism IDO1 inhibitors(Indoleamine 2,3-dioxygenase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 1 | Denmark | 01 Jun 2010 |